The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 11,104,911 | 499,996 | SH | SOLE | 499,996 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 4,837,400 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 18,216,162 | 621,712 | SH | SOLE | 621,712 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 9,003,750 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 163,403,600 | 3,160,000 | SH | SOLE | 3,160,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 51,342,236 | 2,482,700 | SH | SOLE | 2,482,700 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 7,203,518 | 324,629 | SH | SOLE | 324,629 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 7,115,122 | 933,743 | SH | SOLE | 933,743 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 33,935,509 | 761,398 | SH | SOLE | 761,398 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 230,850 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 66,854,619 | 2,551,703 | SH | SOLE | 2,551,703 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 11,657,184 | 1,859,200 | SH | SOLE | 1,859,200 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 1,698,600 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 4,249,010 | 1,958,069 | SH | SOLE | 1,958,069 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 11,692,833 | 220,953 | SH | SOLE | 220,953 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 8,690,850 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 27,361,980 | 1,278,000 | SH | SOLE | 1,278,000 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 1,554,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 750,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 33,982,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,950,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 744,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 1,904,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 1,650,000 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 16,551,611 | 199,417 | SH | SOLE | 199,417 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 7,046,699 | 763,456 | SH | SOLE | 763,456 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 21,348,059 | 474,929 | SH | SOLE | 474,929 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 12,870,769 | 665,156 | SH | SOLE | 665,156 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 64,488,840 | 2,468,000 | SH | SOLE | 2,468,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 8,182,700 | 870,500 | SH | SOLE | 870,500 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 24,074,882 | 824,200 | SH | SOLE | 824,200 | 0 | 0 | ||
XILIO THERAPEUTICS INC | COM | 98422T100 | 6,523,250 | 2,425,000 | SH | SOLE | 2,425,000 | 0 | 0 |